TY - JOUR
T1 - Cancer-related fatigue, version 2.2015
AU - Berger, Ann M.
AU - Mooney, Kathi
AU - Alvarez-Perez, Amy
AU - Breitbart, William S.
AU - Carpenter, Kristen M.
AU - Cella, David
AU - Cleeland, Charles
AU - Dotan, Efrat
AU - Eisenberger, Mario A.
AU - Escalante, Carmen P.
AU - Jacobsen, Paul B.
AU - Jankowski, Catherine
AU - LeBlanc, Thomas
AU - Ligibel, Jennifer A.
AU - Loggers, Elizabeth Trice
AU - Mandrell, Belinda
AU - Murphy, Barbara A.
AU - Palesh, Oxana
AU - Pirl, William F.
AU - Plaxe, Steven C.
AU - Riba, Michelle B.
AU - Rugo, Hope S.
AU - Salvador, Carolina
AU - Wagner, Lynne I.
AU - Wagner-Johnston, Nina D.
AU - Zachariah, Finly J.
AU - Bergman, Mary Anne
AU - Smith, Courtney
N1 - Publisher Copyright:
© JNCCN - Journal of the National Comprehensive Cancer Network.
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent activity and interferes with usual functioning. It is one of the most common side effects in patients with cancer. Fatigue has been shown to be a consequence of active treatment, but it may also persist into posttreatment periods. Furthermore, difficulties in end-of-life care can be compounded by fatigue. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Related Fatigue provide guidance on screening for fatigue and recommendations for interventions based on the stage of treatment. Interventions may include education and counseling, general strategies for the management of fatigue, and specific nonpharmacologic and pharmacologic interventions. Fatigue is a frequently underreported complication in patients with cancer and, when reported, is responsible for reduced quality of life. Therefore, routine screening to identify fatigue is an important component in improving the quality of life for patients living with cancer.
AB - Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent activity and interferes with usual functioning. It is one of the most common side effects in patients with cancer. Fatigue has been shown to be a consequence of active treatment, but it may also persist into posttreatment periods. Furthermore, difficulties in end-of-life care can be compounded by fatigue. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Related Fatigue provide guidance on screening for fatigue and recommendations for interventions based on the stage of treatment. Interventions may include education and counseling, general strategies for the management of fatigue, and specific nonpharmacologic and pharmacologic interventions. Fatigue is a frequently underreported complication in patients with cancer and, when reported, is responsible for reduced quality of life. Therefore, routine screening to identify fatigue is an important component in improving the quality of life for patients living with cancer.
KW - Disease Management
KW - Fatigue/diagnosis
KW - Humans
KW - Neoplasms/complications
KW - Standard of Care
UR - http://www.scopus.com/inward/record.url?scp=84940102853&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000359470200012&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.6004/jnccn.2015.0122
DO - 10.6004/jnccn.2015.0122
M3 - Review article
C2 - 26285247
SN - 1540-1405
VL - 13
SP - 1012
EP - 1039
JO - Journal of the National Comprehensive Cancer Network : JNCCN
JF - Journal of the National Comprehensive Cancer Network : JNCCN
IS - 8
ER -
